Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 5
Submit an article Journal homepage
1,298
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation

Xinmiao JiangInstitution of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
,
Lanping XuInstitution of Hematology, People's Hospital, Peking University, Beijing, China
,
Yu ZhangInstitution of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
,
Fen HuangInstitution of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
,
Daihong LiuInstitution of Hematology, People's Hospital, Peking University, Beijing, China
,
Jin SunInstitution of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
,
Chaoyang SongInstitution of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
,
Xinquan LiangThe First People's Hospital of Chenzhou, Chenzhou, China
,
Zhiping FanInstitution of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
,
Hongsheng ZhouInstitution of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
,
Min DaiInstitution of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
,
Can LiuInstitution of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
,
Qianli JiangInstitution of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
,
Na XuInstitution of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
,
Li XuanInstitution of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
,
Meiqing WuInstitution of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
,
Xiaojun HuangInstitution of Hematology, People's Hospital, Peking University, Beijing, ChinaCorrespondence[email protected]
&
Qifa LiuInstitution of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaCorrespondence[email protected]
 show all
Article: e1139274 | Received 19 Oct 2015, Accepted 03 Jan 2016, Published online: 10 Mar 2016

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Carole Fournier, François Martin, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Lionel Apetoh. (2017) Trial Watch: Adoptively transferred cells for anticancer immunotherapy. OncoImmunology 6:11.
Read now

Articles from other publishers (17)

Sabine Tischer-Zimmermann, Agnes Bonifacius, Maria Michela Santamorena, Philip Mausberg, Sven Stoll, Marius Döring, Ulrich Kalinke, Rainer Blasczyk, Britta Maecker-Kolhoff & Britta Eiz-Vesper. (2023) Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab. Frontiers in Immunology 14.
Crossref
Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, Maurizio Zizzo, Giovanni Martino, Cecilia Caprera, Valentina Fragliasso, Alessandra Soriano, Fabrizio Gozzi, Luca Cimino, Francesco Masia, Marina Moretti, Moira Foroni, Loredana De Marco, David Pellegrini, Hendrik De Raeve, Stefano Ricci, Ione Tamagnini, Alessandro Tafuni, Alberto Cavazza, Francesco Merli, Stefano A. Pileri & Stefano Ascani. (2021) EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3). Cancers 13:23, pages 6021.
Crossref
Nan Yan, Na Wang, Peiling Zhang, Gaoxiang Wang, Xia Mao, Dan Peng, Dong Kuang, Liting Chen, Li Zhu, Jianfeng Zhou, Yicheng Zhang & Yang Cao. (2021) Case Report: Successful Chimeric Antigen Receptor T Cell Therapy in Haploidentical-Allogeneic Stem Cell Transplant Patients With Post-Transplant Lymphoproliferative Disorder. Frontiers in Oncology 11.
Crossref
Francesco Pegoraro & Claudio Favre. (2021) Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation. Annals of Hematology 100:4, pages 865-878.
Crossref
Vedat Uygun, Gülsün Karasu, Hayriye Daloğlu, Seda Öztürkmen, Koray Yalçın, Safiye Suna Çelen & Akif Yeşilipek. (2020) Use of low cell dose for unmanipulated donor lymphocyte for management of cytomegalovirus infection: A single‐center experience. Pediatric Transplantation 24:8.
Crossref
Xue-Yi Luo, Xiao-Dong Mo, Lan-Ping Xu, Xiao-Hui Zhang, Yu Wang, Kai-Yan Liu, Ying-Jun Chang, Xiang-Yu Zhao & Xiao-Jun Huang. (2020) A retrospective analysis on anti-CD20 antibody–treated Epstein–Barr virus–related posttransplantation lymphoproliferative disorder following ATG-based haploidentical T-replete hematopoietic stem cell transplantation. Annals of Hematology 99:11, pages 2649-2657.
Crossref
Sabrina Basso, Francesca Compagno, Paola Zelini, Giovanna Giorgiani, Stella Boghen, Elena Bergami, Jessica Bagnarino, Mariangela Siciliano, Claudia Del Fante, Mario Luppi, Marco Zecca & Patrizia Comoli. (2020) Harnessing T Cells to Control Infections After Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Immunology 11.
Crossref
Francesca Compagno, Sabrina Basso, Arianna Panigari, Jessica Bagnarino, Luca Stoppini, Alessandra Maiello, Tommaso Mina, Paola Zelini, Cesare Perotti, Fausto Baldanti, Marco Zecca & Patrizia Comoli. (2020) Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives. Frontiers in Immunology 11.
Crossref
Valeria Ferla, Francesca Gaia Rossi, Maria Cecilia Goldaniga & Luca Baldini. (2020) Biological Difference Between Epstein–Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact. Frontiers in Oncology 10.
Crossref
Ayumi Fujimoto & Ritsuro Suzuki. (2020) Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes. Cancers 12:2, pages 328.
Crossref
Li Liu, Qifa Liu & Sizhou Feng. (2020) Management of Epstein–Barr virus-related post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation. Therapeutic Advances in Hematology 11, pages 204062072091096.
Crossref
Ren Lin, Yu Wang, Fen Huang, Zhiping Fan, Shen Zhang, Ting Yang, Yajing Xu, Na Xu, Li Xuan, Jieyu Ye, Jing Sun, Xiaojun Huang & Qifa Liu. (2019) Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study. BMC Medicine 17:1.
Crossref
Meng Lv, Yingjun Chang & Xiaojun Huang. (2018) Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation. Frontiers of Medicine 13:1, pages 45-56.
Crossref
Daan Dierickx & Vibeke Vergote. (2019) Management of post-transplant lymphoproliferative disorders. HemaSphere 3, pages 74-77.
Crossref
Kari L. Bjornard, Vasiliki Leventaki, Kim E. Nichols, John T. Sandlund, Susan Prockop & Matthew J. Ehrhardt. (2018) Two-year-old female with EBV-positive diffuse large B-cell lymphoma and subsequent CNS involvement with neurolymphomatosis. Pediatric Blood & Cancer 65:12, pages e27415.
Crossref
Christin B. DeStefano, Sanjal H. Desai, Aarthi G. Shenoy & Joseph P. Catlett. (2018) Management of post-transplant lymphoproliferative disorders. British Journal of Haematology 182:3, pages 330-343.
Crossref
Li Liu, Xuyan Zhang & Sizhou Feng. (2018) Epstein-Barr Virus-Related Post-Transplantation Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 24:7, pages 1341-1349.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.